Filter
481 - 490 of 1342 results
Results for
Spotlight On: Transitioning Local Organizations to Self-Sufficiency
Spotlight On
As a provider of technical assistance (TA), Abt recognizes that the measure of our success ultimately is the ability of TA recipients to operate on their own.
Comprehensive Evaluation of Roca Inc.
Project
Roca, Inc., a non-profit organization, aims to foster behavior change and improve outcomes for high-risk young adults. Recently, Roca has expanded its program throughout Massachusetts and to Baltimore, MD, and introduced a behavior change curriculum to…
AI-Driven Efficiency in Public Service: A Q&A with Nora Connor
Blog
Government agencies can use artificial intelligence to make better decisions and be more efficient while using Abt’s tools to mitigate risk.
The 2019-2020 Annual Homeless Assessment Report (AHAR) to Congress: Pt. 2
Publication
Part 2 of the AHAR showed that overall sheltered homelessness was down while introducing new elements to the data collection.
Success Boston: Evaluating Transition Coaching for College Success
Project
A 2008 report showed only 35 percent of Boston public school graduates who had enrolled in college had completed a postsecondary credential within seven years of graduation. To improve completion rates, the Boston Foundation, the city of Boston, Boston…
Arrestee Drug Abuse Monitoring Program (ADAM) II: 2013 Annual Report
Publication
Evaluation of CMMI Accountable Care Organization Initiatives: Pioneer ACO Evaluation Findings from Performance Years One and Two
Publication
Monitoring Flu Vaccination Coverage among Pregnant Women and Health Care Personnel
Project
Pregnant woman and health care personnel (HCP) need flu shots, yet coverage for these groups historically has been below national targets. Without shots, the groups’ health risks soar. Pregnant women who get the flu not only can contract severe diseases…
Evaluating the Cell and Gene Therapy Access Model
Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.